NEW YORK, March 24, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased BT Group plc (NYSE:BT) securities between May 23, 2013 and January 23, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/bt-group-plc. There is no cost or obligation to you.
According to the complaint, BT Group made false and/or misleading statements and/or failed to disclose that: (i) BT Group’s Italian division had engaged in improper accounting practices; (ii) as a result, BT Group significantly overstated its earnings; (iii) the aforementioned would foreseeably cause BT Group to cut its revenue, earnings, and free cash flow forecasts; and (iv) as a result, BT Group’s public statements were materially false and misleading.
On October 27, 2016, the Company announced that it uncovered “inappropriate management behavior” at its Italian division and “identified certain historical accounting errors and reassessed certain areas of management judgment.” As a result, the Company announced that it had “written down the value of items on the balance sheet by £145 [million].” Then, on January 24, 2017, BT Group issued a news release “the adjustments identified have increased from the £145m announced in our half-year update to a total of around £530m.”
If you suffered a loss in BT Group you have until March 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/bt-group-plc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 



